CU Anschutz Psilocybin Study Offers New Hope for Cancer Patients Facing Emotional Distress

Researchers at the University of Colorado Anschutz Medical Campus are leading one of the nation’s largest federally funded studies exploring psilocybin’s ability to relieve anxiety and existential distress in cancer patients. The clinical trial, supported by the National Cancer Institute, has already helped participants like Teresa Anne Volgenau find mental clarity, emotional healing, and a renewed sense of peace.